Vistin Pharma ASA: Invitation to Q4 2023 conference call
2024年2月9日 - 6:00PM
RNSを含む英国規制内ニュース (英語)
Vistin Pharma ASA: Invitation to Q4 2023 conference call
Oslo, Norway, 9 February 2024
Vistin Pharma ASA will release its fourth quarter and
preliminary 2023 results on Friday 16th of February
2024. Vistin Pharma will host a conference call for all
shareholders and interested parties at the same
day; Friday 16th of February at 08:30 CET.
There will be a Q&A session following the management
discussion.
The conference call will be held in English.
The fourth quarter conference call will be available via web and
audio through the following access points:
Webcast:
https://edge.media-server.com/mmc/p/zfievj3m
Telephone conference (online registration):
https://register.vevent.com/register/BI4f66989ce55146f7ba76754c37cdec44
*****
For further information, please contact:
Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company
producing Metformin Hydrochloride (API). The Metformin is also
available as Direct Compressible lubricated granules. As a solely
dedicated European Metformin producer, Vistin Pharma is a
well-positioned supplier to leading pharmaceutical companies.
Vistin Pharma is headquartered in Oslo, Norway, and has highly
qualified employees and a dedicated manufacturing facility in
Kragerø.
Vistin Pharma Asa (LSE:0RAM)
過去 株価チャート
から 9 2024 まで 10 2024
Vistin Pharma Asa (LSE:0RAM)
過去 株価チャート
から 10 2023 まで 10 2024